brand logo

Am Fam Physician. 2020;102(11):692-693

Clinical Question

Which adult patients with a history of penicillin allergy will have positive allergy testing?

Bottom Line

A label of penicillin allergy clears the shelves of many effective treatments for various infections. A simple rule outlined in the synopsis effectively identifies (without allergy testing) low-risk penicillin allergies in patients with a history of a penicillin allergy event. (Level of Evidence = 1a)

Synopsis

The PEN-FAST rule was developed using a group of 622 patients with a history of reacting to penicillin who were referred for allergy testing, and then validated on a second group of 945 patients who were referred for allergy testing at three other sites. Allergy testing consisted of skin prick, intradermal, or patch testing, with a positive test confirmed by oral challenge. In the validation group, 27.4% reported a history of angioedema and/or anaphylaxis. Following testing in this group, the prevalence of reacting to any allergy test was 9.9%, but only 21 participants reacted to the oral challenge (2.2%). For patients who report a PENicillin allergy, here is the FAST rule:

  • F (five years or less since the reaction): 2 points

  • A (anaphylaxis or angioedema) or S (severe cutaneous reaction): 2 points

  • T (treatment required for reaction): 1 point

Patients with a score of 0 had a likelihood of a positive test result of less than 1%; a score of 1 or 2 yielded a positive test result in 5%. Among the three cohorts, sensitivity ranged from 70.4% (prevalence 27%) to 87.5% (prevalence 14.4%).

Study design: Decision rule (validation)

Setting: Outpatient (any)

Reference:TrubianoJAVogrinSChuaKYLet alDevelopment and validation of a penicillin allergy clinical decision rule. JAMA Intern Med2020;180(5):1–9.

Editor's Note: Dr. Shaughnessy is an assistant medical editor for AFP.

Already a member/subscriber?  Log In

Subscribe

From $145
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available

Article Only

$25.95
  • Immediate, unlimited access to just this article
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, editor-in-chief.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading

More in AFP

More in Pubmed

Copyright © 2020 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.